MBNL1 hijacks a structured single-stranded distal DNA element to sustain FLT3 expression in KMT2A-rearranged leukemias
Science Advances · 07.08.2026 · 12 (32)
DOI: 10.1126/sciadv.aec2331 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, erschienen am 07.08.2026. Verfasst von Meixia Che und 9 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Pharmaceutical Biotechnology, Department of Oncology, Nanjing Drum Tower Hospital, School of Life Sciences, Chemistry and Bio…. Hauptthemen laut MEDLINE: fms-Like Tyrosine Kinase 3, Myeloid-Lymphoid Leukemia Protein, DNA, Single-Stranded, RNA-Binding Proteins. Die Arbeit nennt 72 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: American Cancer Society, American Lebanese Syrian Associated Charities, V-Foundation.
Abstract (Originalsprache)
The molecular mechanisms by which KMT2A-rearranged (KMT2A-r) leukemias maintain the oncogenic FLT3 expression remain largely unclear, limiting therapeutic opportunities. Here, we identify the RNA binding protein MBNL1 as an unexpected positive regulator of FLT3 by DepMap dataset exploration and combinatorial CRISPR screens. MBNL1 promotes leukemia cell survival in cell lines and primary tumors by sustaining FLT3 expression in a KMT2A-r context-dependent manner. Mechanistically, we discover that MBNL1 recognizes a structured single-stranded DNA (ssDNA) element containing five consecutive guanines within the FLT3 enhancer, through MBNL1’s zinc finger domains and the carboxyl-terminal unstructured region. Such MBNL1 protein/ssDNA interaction was evident in KMT2A-r leukemia using ChIP-seq and KAS-seq. Mutations of key amino acids of MBNL1’s ssDNA binding surface or the critical guanines in ssDNA markedly abrogate the protein-ssDNA interactions. These findings implicate MBNL1 as a distinct FLT3 activator by recognizing a structured enhancer ssDNA element, highlighting an unexpected role for RNA binding proteins in transcriptional regulation through direct ssDNA recognition.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Pharmaceutical Biotechnology, Department of Oncology, Nanjing Drum Tower Hospital, School of Life Sciences, Chemistry and Biomedicine Innovation Center (ChemBIC), Nanjing University, 210023 Nanji…
- Division of Molecular Oncology/Cancer Biology Program, Comprehensive Cancer Center, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.
- Department of Hematology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.
- Cyrus Tang Medical Institute, National Clinical, Research Center for Hematologic Disease, State Key Laboratory of Radiation Medicine and Protection, Collaborative Innovation Center of Hematology, Suzhou Medical College,…
- Center for Applied Bioinformatics, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.
ORCID-Profile: Meixia Che, Shaela Fields, Mengli Zhang, Beisi Xu, Peng Xu, Yajun Jiang, Chunliang Li
Förderung
- American Cancer Society
- American Lebanese Syrian Associated Charities
- V-Foundation
Zitieren
APA
Che, M., Fields, S., Yi, S., Hyle, J., Zhang, M., Xu, B., Cheng, Y., Xu, P., Jiang, Y., & Li, C. (2026). MBNL1 hijacks a structured single-stranded distal DNA element to sustain FLT3 expression in KMT2A-rearranged leukemias. Science Advances, 12(32). https://doi.org/10.1126/sciadv.aec2331
Vancouver
Che M, Fields S, Yi S, Hyle J, Zhang M, Xu B, et al. MBNL1 hijacks a structured single-stranded distal DNA element to sustain FLT3 expression in KMT2A-rearranged leukemias. Science Advances. 2026;12(32). doi:10.1126/sciadv.aec2331
BibTeX
@article{Che2026,
author = {Che, Meixia and Fields, Shaela and Yi, Siqi and Hyle, Judith and Zhang, Mengli and Xu, Beisi and Cheng, Yong and Xu, Peng and Jiang, Yajun and Li, Chunliang},
title = {MBNL1 hijacks a structured single-stranded distal DNA element to sustain FLT3 expression in KMT2A-rearranged leukemias},
journal = {Science Advances},
year = {2026},
volume = {12},
number = {32},
doi = {10.1126/sciadv.aec2331}
}
EUVIMED